CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION

CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION

Show other versions (1)

The article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination. 2 vaccines, which are approved by the FDA end EMEA for use and are registered in R...

Full description

Bibliographic Details
Main Authors: E.V. Uvarova, Z.Kh. Kumykova
Format: Article
Language:English
Published: Paediatrician Publishers, LLC 2011-01-01
Series:Pediatričeskaâ Farmakologiâ
Online Access:https://www.pedpharma.ru/jour/article/view/742
id doaj-fa4768ab85f34663b1140beb4a51b70b
record_format Article
spelling doaj-fa4768ab85f34663b1140beb4a51b70b2021-07-28T16:32:31ZengPaediatrician Publishers, LLCPediatričeskaâ Farmakologiâ1727-57762500-30892011-01-01811721737CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTIONE.V. Uvarova0Z.Kh. Kumykova1V.I. Kulakov Federal State Institute Research Centre of Obstetrics, Gynecology and Perinatology of Russia’s Agency of Healthcare and Social DevelopmentV.I. Kulakov Federal State Institute Research Centre of Obstetrics, Gynecology and Perinatology of Russia’s Agency of Healthcare and Social DevelopmentThe article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination. 2 vaccines, which are approved by the FDA end EMEA for use and are registered in Russia, have been created and are successfully used for this purpose. The authors believe that the best results may be achieved by combining screening examination programmes with universal reasonable administration of scheduled voluntary vaccination of Russia’s population.Key words: human papilloma virus, HPV infection, cervical cancer, malignancies, prevention, vaccination.https://www.pedpharma.ru/jour/article/view/742
collection DOAJ
language English
format Article
sources DOAJ
author E.V. Uvarova
Z.Kh. Kumykova
spellingShingle E.V. Uvarova
Z.Kh. Kumykova
CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION
Pediatričeskaâ Farmakologiâ
author_facet E.V. Uvarova
Z.Kh. Kumykova
author_sort E.V. Uvarova
title CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION
title_short CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION
title_full CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION
title_fullStr CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION
title_full_unstemmed CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION
title_sort critical issues of papilloma virus infection prevention
publisher Paediatrician Publishers, LLC
series Pediatričeskaâ Farmakologiâ
issn 1727-5776
2500-3089
publishDate 2011-01-01
description The article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination. 2 vaccines, which are approved by the FDA end EMEA for use and are registered in Russia, have been created and are successfully used for this purpose. The authors believe that the best results may be achieved by combining screening examination programmes with universal reasonable administration of scheduled voluntary vaccination of Russia’s population.Key words: human papilloma virus, HPV infection, cervical cancer, malignancies, prevention, vaccination.
url https://www.pedpharma.ru/jour/article/view/742
work_keys_str_mv AT evuvarova criticalissuesofpapillomavirusinfectionprevention
AT zkhkumykova criticalissuesofpapillomavirusinfectionprevention
_version_ 1721265923090808832

Similar Items